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Abstract
Background: Human mammary tumor virus (HMTV) is 90–95% homologous to mouse mammary tumor virus
(MMTV), one of the causal agents of murine mammary tumors. HMTV (MMTV-like) sequences were reported to be
present in human breast cancers from several populations with a prevalence range of 0–78%; however, the
prevalence of HMTV in breast cancers from Myanmar remains unknown.
Methods: Fifty-eight breast cancer samples from Myanmar women were examined in this study. DNA was isolated
from formalin-fixed paraffin-embedded specimens, and HMTV envelope sequences were detected by semi-nested
PCR. The sequence of the PCR products was also confirmed.
Results: Only 1.7% (1 of 58) of the breast cancers were positive for HMTV, and the sequence of PCR products was
98.9% identical to the reference HMTV sequence (GenBank accession No. AF243039). The tumor with HMTV was
grade III invasive ductal carcinoma, 7.0 cm in size with lymph node metastasis (T3, N1, M0).
Conclusions: We, for the first time, investigated the presence of HMTV in Myanmar breast cancer patients. In
accordance with other Asian studies, the prevalence of HMTV in Myanmar was quite low, supporting the hypothesis
that Asian breast cancers have different etiologies than in Western countries, where HMTV is more prevalent.
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Background
Worldwide, breast cancer is the most frequently diag-
nosed cancer affecting women, with an estimated 1.7
million cases and 521,900 deaths in 2012 [1, 2]. The
incidence of breast cancer is higher in developed
countries, while the mortality is higher in developing
countries. These discrepancies in incidence and
mortality are attributed to early detection as well as
risk factors including geographic variation, racial/eth-
nic background, genetic variation, lifestyle, and repro-
ductive patterns associated with urbanization and
economic development [3, 4].
The etiology of human breast cancer can be signifi-
cantly affected by environmental factors, including
viruses [5, 6]. Among them, mouse mammary tumor
virus (MMTV) is a non-acute transforming type B retro-
virus that causes the majority of mammary tumors in
mice. MMTV induces premalignant lesions and malig-
nant tumors of the breast by acting as an insertional
mutagen or activating the transcription of nearby
oncogenes [7, 8]. In 1995, retroviral sequences 90–95%
homologous to MMTV were detected in 39% of human
breast cancers in the United States [9]. Subsequently, a
9.9-kb proviral structure, which was 95% homologous to
MMTV, was successfully amplified from two distinct
human breast cancers. The retrovirus with MMTV-like
sequence was subsequently designated human mammary
tumor virus (HMTV) [10]. Very recently, MMTV-like
sequences were found in breast tissues prior to the
development of virus-positive breast cancer, indicating a
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possible causal role in the development of breast cancer
[11]. To understand the involvement of HMTV/MMTV-
like sequence in the carcinogenesis of breast cancer, it is
important to obtain more clinical and epidemiological
data in breast cancer worldwide.
As with other countries, breast cancer is a leading
cause of morbidity and mortality in Myanmar women
[12]. The purpose of this study was to investigate the
prevalence of HMTV in breast cancers in Myanmar.
Methods
Study subjects
In this study, we employed 58 breast cancer cases diag-
nosed in 2015 at Myeik General Hospital (Myeik City,
Myanmar) and Sakura Specialist Hospital (Yangon City,
Myanmar). All hematoxylin and eosin-stained sections
were reviewed by two independent pathologists. The cri-
teria defined by the World Health Organization (2012)
were used for the histopathological diagnosis and classifi-
cation of breast carcinoma [13]. Nottingham combined
histological grading system [14] was used for tumor grad-
ing. American Joint Committee on Cancer staging system
8th edition was applied for tumor staging. The experimen-
tal protocol employed in this study was approved by the
Ethics Committee of Okayama University and the Ethics
Review Committee of Department of Medical Research of
Yangon City (Myanmar).
DNA extraction
Two to four 10-μm-thick sections were cut from each
paraffin block, and genomic DNA was extracted using
the Nucleospin DNA FFPE XS kit (Macherey-Nagel,
Düren, Germany) according to the manufacturer’s in-
structions. The amount of extracted DNA was measured
on a Nanodrop 1000 spectrophotometer (Thermo Fisher
Scientific, Waltham, MA, USA). The A260:A280 ratio
was used to measure the purity of DNA (~1.80). DNA
quality was also confirmed by PCR amplification of the
268 bp β-globin gene using GH20 and PC04 primers
(Table 1). All samples employed in this study were
qualified for HMTV detection.
Detection of HMTV sequence by PCR
The detection of HMTV DNA sequences was performed
using a semi-nested PCR approach. Primers were care-
fully selected from those stated to successfully amplify
HMTV sequences in previous literature [15–18]. In the
first-round of PCR, primers 5 F and MR1 were used to
amplify a 246-bp segment. In the second-round of PCR,
the same forward primer (5 F) and a different reverse
primer (2NR) were used to amplify a 189-bp HMTV
sequence. PCR reactions were performed in a 20 μl
volume and contained 0.02 μM and 0.2 μM of primers,
together with reagents from the Pyromark PCR kit
(QIAGEN, Hilden, Germany) according to the manufac-
turer’s instructions. Approximately 250 ng of extracted
DNA was used as template for first-round PCR and 2 μl
of first-round PCR product was used as template for
second-round PCR. PCR products were electrophoresed
on 2% agarose gels containing ethidium bromide and vi-
sualized with ultraviolet light. RCB0526:Jyg-MC(A) cells
(Riken Bioresource Center, Tsukuba, Japan), a murine
mammary tumor cell line expressing high MMTV levels,
were cultivated, harvested and the extracted DNA was
used as a positive control.
To exclude murine DNA contamination in the
HMTV-positive sample, mouse-specific mitochondrial
(mt) DNA was amplified by semi-nested PCR using the
primers mt15982F and mt16267R for the first-round
PCR and mt16115F and mt16267R for the second-round
PCR, which yielded a final PCR product of 153-bp. DNA
extracted from the 4 T1 murine breast cancer cell line
was used as positive control.
The list of all primers used and their positions in the
genome are shown in Table 1. PCR conditions were as
follows: β-globin: 95 °C for 15 min, 40 cycles of 95 °C
for 30 s, 55 °C for 30 s, and 72 °C for 1 min, and then
72 °C for 7 min; HMTV: first-round PCR: 95 °C for
Table 1 List of primers, their sequences and positions in the genome
gene primer sequence (5´–3´) nucleotide position
β-globin GH20 GAAGAGCCAAGGACAGGTAC 1417-1436a
PC04 CAACTTCATCCACGTTCACC 1684-1665a
HMTV 5 F GTATGAAGCAGGATGGGTAGA 235-255b
MR1 CCTCTTTTCTCTATATCTATTAGCTGAGGTAATC 480-446b
2NR GTAACACAGGCAGATGTAGG 423-404b
mt DNA mt15982F AGACGCACCTACGGTGAAGA 15982-16001c
mt16115F TGCCAAACCCCAAAAACACT 16115-16134c
mt16267R AGAGTTTTGGTTCACGGAACATGA 16267-16244c
aRefers to Homo sapiens β-globin gene, complete cds (Genbank AH001475)
bRefers to human mammary tumor virus SAG pseudogene, complete sequence (Genbank AF243039)
cRefers to Mus musculus complete mitochondrial genome, strain Balb/cJ (Genbank AJ512208)
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15 min and 40 cycles of 30 s at 95 °C, 30 s at 58 °C and
1 min at 72 °C, and then 72 °C for 7 min; second-round
PCR: 95 °C for 15 min and 35 cycles of 30 s at 95 °C,
30 s at 60 °C and 1 min at 72 °C, and then 72 °C for
7 min; mt DNA: first-round PCR: 95 °C for 15 min and
40 cycles of 30 s at 95 °C, 30 s at 55 °C and 1 min at
72 °C, and then 72 °C for 7 min; second-round PCR:
95 °C for 15 min and 35 cycles of 30 s at 95 °C, 30 s at
55 °C and 1 min at 72 °C, and then 72 °C for 7 min.
DNA sequencing
Sequencing was performed using an ABI3130xl Genetic
Analyzer (Applied Biosystems, Waltham, MA, USA) at
the Central Research Laboratory of Okayama University.
PCR products were isolated from gels, sequenced and
aligned by a BLAST search (NCBI).
Results
Patient characteristics
Clinical data for the 58 breast cancer patients are shown
in Table 2. Ages ranged from 30 to 81 years with a mean
age of 50.3 years. Tumor sizes ranged from 1.5 cm to
7.2 cm with an average size of 4.0 cm. Most of the
cancers (97%) were invasive ductal carcinoma with high
histological grade (grade II and III). No grade I malig-
nancies were found. There were lymph nodes metastases
in 57% of the cases.
Detection of HMTV
Experiments were conducted to analyze the prevalence
of HMTV. Genomic DNA was extracted from each par-
affin block and its quality was measured using the
A260:A280 ratio (>1.80) and a distinct β-globin PCR
product. HMTV sequence was investigated in all 58
samples using semi-nested PCR, which revealed one case
(MB14) was positive for HMTV (Fig. 1). The PCR reac-
tion was confirmed by repeating the semi-nested PCR
using newly extracted DNA from the paraffin block
(not shown). The positive band was cut from the gel,
and the PCR product was sequenced. The complete
189-bp PCR product sequence was aligned to two
published HMTV sequences, and the reference
sequence of the positive control (Fig. 2). The se-
quence was 98.9% identical to the original proviral
HMTV sequence (GenBank AF243039) and HMTV
sequence from Vietnam (GenBank AY161347).
Although MB14-sequence showed 92% homology with
control MMTV (GenBank AK145002), we attempted
to exclude murine DNA contamination in MB14-
DNA. For this, MB14-DNA (250 ng) was amplified
using primers for mouse mitochondrial DNA. 4 T1-
DNA was used as a positive control murine DNA.
The data in Fig. 3 demonstrated that there was no
contamination of murine DNA in MB14-DNA. The
detection limit of this assay was more than 0.8 pg
DNA (Fig. 3). The HMTV-positive case was invasive
carcinoma, 7.0 cm in size, histological grade III, with
lymph node metastasis.
Discussion
HMTV has been detected at different frequencies in
different countries. We, for the first time in this study,
investigated the prevalence of HMTV in breast cancers
in Myanmar. Semi-nested PCR and sequencing data
showed that the prevalence of HMTV was very low
(1.7%, 1 of 58 cases). To the best of our knowledge, the
prevalence of HMTV (MMTV-like) sequences in breast
cancers has been reported for 17 countries, including
the present study. Figure 4 shows the prevalence of
HMTV on the world-map from these reports.
The prevalence of HMTV shows geographic hetero-
geneity. A high prevalence of HMTV was detected in
North and South America, Australia and Mediterranean
countries, where the range is from 12 to 78% (average
49.4%) [18–25]. Conversely, HMTV was not detected in
Central and Northern Europe [26–29]. In Asia, no or
few cases are positive for HMTV in Japan [30], Iran [31],
Vietnam [15] and Myanmar (this study). The prevalence
of HMTV in Myanmar breast cancers (1.7%) is compar-
able to that of a Vietnamese study (0.8%) [15]. More in-
triguingly, the sequence of HMTV reported in the
Vietnamese study (GenBank AY161347) was 98.9%
Table 2 Clinical data for the enrolled breast cancer patients
categories number of cases (%)
Age (years) <35 4 (6.9)
35–50 24 (41.4)
>50 30 (51.7)
Tumor size (cm) ≦2.0 4 (6.9)
2.1–5.0 39 (67.2)
>5.0 15 (25.9)
Pathological
diagnosis
Invasive ductal
carcinoma
56 (96.6)
Mucinous
carcinoma
1 (1.7)
Carcinoma with
neuroendocrine
differentiation
1 (1.7)
Histological grade Grade I 0 (0.0)
Grade II 26 (44.8)
Grade III 32 (55.2)
Lymph node
metastasis
Absent 25 (43.1)
Present 33 (56.9)
Stage Stage I 4 (6.9)
Stage II 30 (51.7)
Stage III 22 (37.9)
Stage IV 2 (3.4)
San et al. Infectious Agents and Cancer  (2017) 12:20 Page 3 of 7
identical to that seen in this Myanmar case, suggesting
there may be a close etiological relationship between the
two countries. Although the prevalence in China and
Pakistan was high (16.8 and 20.0%, respectively) [32, 33],
no sequence was confirmed in the Chinese study, and
only 2 of 16 positive cases were confirmed in the
Pakistani study. A recent study in Iran showed that 12%
of cases were positive, but none of the sequences were
confirmed [34]. These data appear to be contingent and
necessitate further study.
Interestingly, Asian countries with zero or low HMTV
prevalence such as Japan, Vietnam and Myanmar have
low breast cancer incidence (51.5, 23.0 and 22.1 per
100,000 women, respectively) compared with countries
with high HMTV prevalence like the United States, Italy
and Australia (92.9, 91.3 and 86.0 per 100,000 women,
respectively) (http://globocan.iarc.fr.). Breast cancer de-
velops at earlier ages in Asia (peak incidence between 40
and 50 years) than in Western countries (peak incidence
between 60 and 70 years) [35]. These differences may re-
flect distinct characteristics and etiological backgrounds.
There is an interesting report hypothesizing that human
breast cancer could be correlated with the natural ranges
of different species of wild mice [36]. Mus domesticus,
having the highest numbers of endogenous MMTV pro-
viral loci, inhabits the United States, Italy and Australia,
where the prevalence of HMTV in breast cancers is
high. On the other hand, M. musculus and M. castaneus,
having the fewest MMTV proviral loci, ranges from
central Europe east to China and Japan and from
southern China to central Iran, respectively.
A question arises about the sensitivity of the detection
system. False negatives may be present in zero or low
prevalence reports as primers and/or reaction conditions
are critical in the detection system [37, 38]; however, this
is unlikely in this study. We employed a highly sensi-
tive methodology (semi-nested PCR) together with a
proper positive control, a murine mammary tumor
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Fig. 1 Gel electrophoresis of PCR products. a. HMTV Semi-nested PCR
was performed using genomic DNA purified from each paraffin-block.
Case numbers from MB11 to MB20 are shown. M, 100-bp DNA ladder;
P, positive control; N, negative control. b. β-globin PCR was performed
using the same DNA as above
Fig. 2 Sequence analysis of the PCR product. Sequence of the PCR product from MB14 is aligned with reference HMTV sequence (AF243039),
HMTV sequence detected in a Vietnamese woman (AY161347) and reference sequence of the MMTV control (AK145002) retrieved from GenBank.
Stars show the conserved sites along the alignment
500 bp
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4T1-DNA(pg) 
M
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Fig. 3 Exclusion of murine DNA contamination in MB14-DNA.
Murine mitochondrial DNA semi-nested PCR was performed using
MB14-DNA (250 ng). Serially diluted DNAs from murine 4 T1 cells
were used as positive controls. M, 100-bp DNA ladder
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cell line expressing high level MMTV. We estimated
the detection limit of this semi-nested PCR method
using serially diluted positive control DNA, which
was highly sensitive (as little as 80 pg of DNA, not
shown). In addition, the primers and PCR conditions
used in this study are same as those in previous
studies [15–18].
It would be interesting if there was a correlation
between HMTV status and clinicopathological para-
meters. Although several reports demonstrated causal
association between these [16, 17, 24, 39], no strong
correlation could be found after comprehensive meta-
analysis [40]. The HMTV-positive case in this study
showed histological grade III with lymph node metas-
tasis. Further studies may reveal some unexplored or
unnoticed characteristics of HMTV-associated breast
cancers.
Conclusions
This is the first study to report the prevalence of HMTV
in breast cancers in Myanmar. The prevalence of HMTV
in Myanmar was consistent with other Asian countries
with low or zero prevalence. The frequency of infection
and HMTV sequence closely resembled that from
Vietnam. It appears that HMTV does not play an
important role in breast cancer carcinogenesis in most
Asian populations.
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